Healthcare Services Group, Inc. (HCSG) vs Rapport Therapeutics, Inc. Common Stock (RAPP)

A side-by-side comparison of Healthcare Services Group, Inc. and Rapport Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Healthcare Services Group, Inc. logo
HCSG
Healthcare Services Group, Inc.
$1.45B
$21.13HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Rapport Therapeutics, Inc. Common Stock logo
RAPP
Rapport Therapeutics, Inc. Common Stock
$1.49B
$31.15HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — HCSG vs RAPP

growth of $100 · dividends reinvested · last 2y
HCSG +103.2% (+42.5%/yr)RAPP +54.8% (+24.4%/yr)HCSG compounded faster over this window
50100150200250Start $10020252026$203$155
HCSG RAPP

HCSG vs RAPP: by the numbers

  • •RAPP is the larger company ($1.49B vs $1.45B market cap).
  • •HCSG is profitable (6.59% net margin) while RAPP runs a net loss (-685.80%).

Metrics side by side

Valuation

MetricHCSGRAPP
P/E ratio12.36N/A
Forward P/E17.62N/A
P/S ratio0.7874.49
P/B ratio2.803.52
EV / EBITDA8.94N/A
FCF yield10.44%N/A

Profitability

MetricHCSGRAPP
Gross margin17.33%0.00%
Operating margin7.03%0.00%
Net margin6.59%-685.80%
ROE23.70%-32.43%
ROIC16.83%-35.66%

Growth (annualized)

MetricHCSGRAPP
Revenue CAGR (5Y)2.29%N/A
EPS CAGR (5Y)-9.08%N/A
FCF CAGR (5Y)-8.15%N/A
Total return CAGR (5Y)-2.00%N/A

Frequently asked

Is HCSG or RAPP more profitable?
HCSG runs the higher net margin — HCSG at 6.59% versus RAPP at -685.80%.

Go deeper

Full HCSG analysisFull RAPP analysisInteractive comparison tool

Dig into the metrics

Healthcare Services P/E ratioHealthcare Services ROERapport Therapeutics, Inc. Common Stock ROEHealthcare Services operating marginRapport Therapeutics, Inc. Common Stock operating marginHealthcare Services revenue growthRapport Therapeutics, Inc. Common Stock revenue growthHealthcare Services free cash flowRapport Therapeutics, Inc. Common Stock free cash flow

Healthcare Services & Rapport Therapeutics, Inc. Common Stock appear in these rankings

Highest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.